Total Payments
$5,161
2024 Payments
$483.66
Companies
35
Transactions
313
Medicare Patients
840
Medicare Billing
$48,007
Payment Breakdown by Category
Food & Beverage$5,102 (98.8%)
Gifts$59.40 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,102 | 312 | 98.8% |
| Gift | $59.40 | 1 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $855.39 | 55 | $0 (2024) |
| ABBVIE INC. | $681.44 | 46 | $0 (2024) |
| Novo Nordisk Inc | $666.24 | 43 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $357.51 | 21 | $0 (2023) |
| Amgen Inc. | $295.92 | 18 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $279.02 | 14 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $255.48 | 15 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $247.47 | 15 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $169.19 | 8 | $0 (2023) |
| IDORSIA PHARMACEUTICALS US INC | $144.92 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $483.66 | 26 | Novo Nordisk Inc ($97.67) |
| 2023 | $1,623 | 95 | Lilly USA, LLC ($348.00) |
| 2022 | $1,542 | 92 | ABBVIE INC. ($236.29) |
| 2021 | $1,513 | 100 | Lilly USA, LLC ($221.64) |
All Payment Transactions
313 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/02/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Obesity | ||||||
| 05/29/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Diabetes | ||||||
| 04/30/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: NEUROSCIENCE | ||||||
| 04/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Obesity | ||||||
| 04/10/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/08/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Diabetes Care | ||||||
| 04/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Diabetes | ||||||
| 03/28/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Respiratory | ||||||
| 03/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Obesity | ||||||
| 03/21/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Diabetes | ||||||
| 03/19/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: NEUROLOGY | ||||||
| 03/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: NEUROSCIENCE | ||||||
| 03/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/11/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Diabetes | ||||||
| 03/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: Inflammation | ||||||
| 03/06/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/04/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/28/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Diabetes | ||||||
| 02/23/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: Diabetes | ||||||
| 02/14/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $27.21 | General |
| 02/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Obesity | ||||||
| 02/01/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $27.18 | General |
| Category: Inflammation | ||||||
| 01/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Obesity | ||||||
| 01/04/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 367 | 797 | $79,634 | $21,380 |
| 2022 | 12 | 417 | 856 | $85,338 | $23,756 |
| 2021 | 3 | 56 | 61 | $9,177 | $2,871 |
Total Patients
840
Total Services
1,714
Medicare Billing
$48,007
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 121 | 270 | $60,750 | $16,660 | 27.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 14 | 14 | $2,450 | $1,381 | 56.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 33 | $4,950 | $1,217 | 24.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 82 | 110 | $2,310 | $924.00 | 40.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $2,700 | $544.80 | 20.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 44 | 66 | $3,300 | $506.89 | 15.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 30 | 47 | $752.00 | $103.40 | 13.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 24 | 224 | $1,792 | $21.12 | 1.2% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 14 | 21 | $630.00 | $20.81 | 3.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 124 | 272 | $61,200 | $17,414 | 28.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 31 | $4,650 | $1,307 | 28.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 11 | 11 | $1,925 | $1,182 | 61.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 13 | 14 | $1,400 | $979.68 | 70.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 15 | 15 | $3,375 | $699.59 | 20.7% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 12 | 14 | $1,400 | $611.50 | 43.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 45 | 87 | $4,350 | $610.68 | 14.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 14 | 15 | $750.00 | $426.28 | 56.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 84 | 126 | $2,646 | $373.20 | 14.1% |
| 81003 | Automated urinalysis test | Office | 2022 | 33 | 44 | $704.00 | $93.17 | 13.2% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 20 | 51 | $1,530 | $44.02 | 2.9% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 17 | 176 | $1,408 | $14.77 | 1.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 33 | 37 | $8,325 | $2,730 | 32.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 11 | 12 | $600.00 | $104.61 | 17.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 12 | 12 | $252.00 | $36.00 | 14.3% |
About Sally Thompson, FNP-C
Sally Thompson, FNP-C is a Nurse Practitioner healthcare provider based in Texarkana, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/19/2013. The National Provider Identifier (NPI) number assigned to this provider is 1003249558.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sally Thompson, FNP-C has received a total of $5,161 in payments from pharmaceutical and medical device companies, with $483.66 received in 2024. These payments were reported across 313 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($5,102).
As a Medicare-enrolled provider, Thompson has provided services to 840 Medicare beneficiaries, totaling 1,714 services with total Medicare billing of $48,007. Data is available for 3 years (2021–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Texarkana, TX
- Active Since 08/19/2013
- Last Updated 04/24/2014
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1003249558
Products in Payments
- Kerendia (Drug) $357.51
- VRAYLAR (Drug) $329.76
- JARDIANCE (Drug) $321.38
- MOUNJARO (Drug) $313.42
- UBRELVY (Drug) $279.53
- XARELTO (Drug) $255.48
- Ozempic (Drug) $250.19
- Wegovy (Drug) $188.66
- BREZTRI (Drug) $164.77
- QUVIVIQ (Drug) $144.92
- TRULICITY (Drug) $139.90
- ELIQUIS (Drug) $137.09
- Rybelsus (Drug) $135.52
- EMGALITY (Drug) $125.42
- Vascepa (Drug) $123.20
- Otezla (Drug) $114.33
- CAPLYTA (Drug) $113.16
- Livalo (Drug) $108.42
- Aimovig (Biological) $101.16
- JANUVIA (Drug) $98.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Texarkana
Mrs. Deanna Padgett, Pmhnp, PMHNP
Nurse Practitioner — Payments: $6,948
Nurse Practitioner $6,948
Cara Cook, Fnp, FNP
Nurse Practitioner — Payments: $6,207
Nurse Practitioner $6,207
Ms. Kimberly Sutton, Fnp, FNP
Nurse Practitioner — Payments: $5,872
Nurse Practitioner $5,872
Brandi Martin, Arpn, Fnp, ARPN, FNP
Nurse Practitioner — Payments: $5,320
Nurse Practitioner $5,320
Sandra Higgs, Aprn, Fnp, Pmhnp-Bc, APRN, FNP, PMHNP-BC
Nurse Practitioner — Payments: $5,185
Nurse Practitioner $5,185
Valerie Crawford, Aprn, APRN
Nurse Practitioner — Payments: $4,153
Nurse Practitioner $4,153